Cargando…
Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
Immature neutrophils and HLA-DR(neg/low) monocytes expand in cancer, autoimmune diseases and viral infections, but their appearance and immunoregulatory effects on T-cells after acute myocardial infarction (AMI) remain underexplored. We found an expansion of circulating immature CD16(+)CD66b(+)CD10(...
Autores principales: | Fraccarollo, Daniela, Neuser, Jonas, Möller, Julian, Riehle, Christian, Galuppo, Paolo, Bauersachs, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324297/ https://www.ncbi.nlm.nih.gov/pubmed/34289931 http://dx.doi.org/10.7554/eLife.66808 |
Ejemplares similares
-
The CD14(+)HLA-DR(lo/neg) Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
por: Mengos, April E., et al.
Publicado: (2019) -
Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013) -
Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients
por: Xue, GuoHui, et al.
Publicado: (2021) -
Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses
por: Laborde, Rebecca R., et al.
Publicado: (2014) -
Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015)